BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37444432)

  • 1. Oncological and Peri-Operative Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma for Patients with Hereditary RCC Diseases-An Analysis of European Multi-Centre Prospective EuRECA Registry.
    Osman FH; Chan VW; Breen DJ; King A; Nielsen TK; Garnon J; Alcorn D; Lagerveld B; Graumann O; Keeley FX; Walkden M; de Kerviler É; Wah TM
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational study.
    Chan VW; Lenton J; Smith J; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Lewington A; Kimuli M; Cartledge J; Wah TM
    Eur J Surg Oncol; 2022 Mar; 48(3):672-679. PubMed ID: 34728141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
    Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
    BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
    Kim EH; Tanagho YS; Bhayani SB; Saad NE; Benway BM; Figenshau RS
    BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological outcomes and complication rates after laparoscopic-assisted cryoablation: a European Registry for Renal Cryoablation (EuRECA) multi-institutional study.
    Nielsen TK; Lagerveld BW; Keeley F; Lughezzani G; Sriprasad S; Barber NJ; Hansen LU; Buffi NM; Guazzoni G; van der Zee JA; Ismail M; Farrag K; Emara AM; Lund L; Østraat Ø; Borre M
    BJU Int; 2017 Mar; 119(3):390-395. PubMed ID: 27488479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of cryoablation for biopsy-proven T1 stage renal cell carcinoma.
    Song S; Yang Q; Gu C; Yu G; Hua B; Gu X; Wang L; Wang Z; Shi G; Xu B
    World J Surg Oncol; 2022 Sep; 20(1):284. PubMed ID: 36064369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience.
    Wah TM; Lenton J; Smith J; Bassett P; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Kimuli M; Cartledge J
    Eur Radiol; 2021 Oct; 31(10):7491-7499. PubMed ID: 33825033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage Percutaneous Cryoablation for Locally Recurrent Renal-Cell Carcinoma After Primary Cryoablation.
    Okhunov Z; Chamberlin J; Moreira DM; George A; Babaian K; Shah P; Youssef R; Kaler KS; Lobko II; Kavoussi L; Landman J
    J Endourol; 2016 Jun; 30(6):632-7. PubMed ID: 27009377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing trends of image-guided biopsy of small renal masses before intervention-an analysis of European multinational prospective EuRECA registry.
    Chan VW; Keeley FX; Lagerveld B; Breen DJ; King A; Nielsen TK; van Strijen M; Garnon J; Alcorn D; Graumann O; de Kerviler E; Zondervan P; Walkden M; Lughezzani G; Wah TM
    Eur Radiol; 2022 Jul; 32(7):4667-4678. PubMed ID: 35122492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomes.
    Grange R; Tradi F; Izaaryene J; Daidj N; Brunelle S; Walz J; Gravis G; Piana G
    Int J Hyperthermia; 2019; 36(1):1065-1071. PubMed ID: 31648584
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and Oncological Outcomes Following Percutaneous Cryoablation vs. Partial Nephrectomy for Clinical T1 Renal Tumours: Systematic Review and Meta-Analysis.
    Nowak Ł; Janczak D; Łaszkiewicz J; Guziński M; Del Giudice F; Tresh A; Chung BI; Chorbińska J; Tomczak W; Małkiewicz B; Szydełko T; Krajewski W
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma.
    Chan VW; Osman FH; Cartledge J; Gregory W; Kimuli M; Vasudev NS; Ralph C; Jagdev S; Bhattarai S; Smith J; Lenton J; Wah TM
    Eur Radiol; 2022 Sep; 32(9):5811-5820. PubMed ID: 35384457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
    Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
    AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparisons of percutaneous versus retroperitoneoscopic cryoablation for renal masses.
    Liu HY; Shen SH; Hsu LN; Chiang PH
    Int Urol Nephrol; 2018 Aug; 50(8):1407-1415. PubMed ID: 30022280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan.
    Uka M; Iguchi T; Okawa N; Matsui Y; Tomita K; Umakoshi N; Munetomo K; Gobara H; Araki M; Hiraki T
    Jpn J Radiol; 2022 Nov; 40(11):1201-1209. PubMed ID: 35727459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Cryoablation for Stage 1 Renal Cell Carcinoma: Outcomes from a 10-year Prospective Study and Comparison with Matched Cohorts from the National Cancer Database.
    Morkos J; Porosnicu Rodriguez KA; Zhou A; Kolarich AR; Frangakis C; Rodriguez R; Georgiades CS
    Radiology; 2020 Aug; 296(2):452-459. PubMed ID: 32515677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.